Novel de novo mutation in ZBTB20 in a Chinese Primrose syndrome family and a review of the literature

ConclusionHowever, there are no formal clinical guidelines for the management of this disease, and research on treatment and prognosis remains a challenge and focus in future.

Source: Molecular Genetics & Genomic Medicine - December 13, 2023 Category: Genetics & Stem Cells Authors: Jiayi Li, Chuan Zhang, Xinyuan Tian, Bingbo Zhou, Xue Chen, Yupei Wang, Shengju Hao, Ling Hui, Zhaoyan Meng Tags: CLINICAL REPORT Source Type: research